VWR SCIENTIFIC PRODUCTS CORP
SC 14D9/A, 1999-07-06
PROFESSIONAL & COMMERCIAL EQUIPMENT & SUPPLIES
Previous: LAMONTS APPAREL INC, 8-K, 1999-07-06
Next: FIRST TRUST COMBINED SERIES 5, 497J, 1999-07-06



<PAGE>   1
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                               -------------------

                                 SCHEDULE 14D-9
                                (Amendment No. 1)
       Solicitation/Recommendation Statement Pursuant to Section 14(d)(4)
                     of the Securities Exchange Act of 1934
                               -------------------

                       VWR SCIENTIFIC PRODUCTS CORPORATION
                            (Name of Subject Company)
                               -------------------

                       VWR SCIENTIFIC PRODUCTS CORPORATION
                      (Name of Person(s) Filing Statement)
                               -------------------

                    Common Shares, Par Value $1.00 Per Share
                         (Title of Class of Securities)
                               -------------------

                                   918435-10-8
                      (CUSIP Number of Class of Securities)
                               -------------------

                                David M. Bronson
                       Senior Vice President and Secretary
                       VWR Scientific Products Corporation
                               1310 Goshen Parkway
                        West Chester, Pennsylvania 19380
                                 (610) 431-1700

  (Name, Address and Telephone Number of Persons Authorized to Receive Notices
                    and Communications on Behalf of Bidders)

                               -------------------

                                    Copy to:
                              Thomas E. Wood, Esq.
                           Drinker Biddle & Reath LLP
                                    Suite 300
                              1000 Westlakes Drive
                           Berwyn, Pennsylvania 19312
                                 (610) 993-2200

                                  July 6, 1999


================================================================================
<PAGE>   2
            This Amendment No. 1 to the Solicitation/Recommendation Statement on
Schedule 14D-9 (this "Amendment") relates to the offer by EM Subsidiary, Inc., a
Pennsylvania corporation ("Purchaser") and a wholly owned subsidiary of EM
Laboratories, Incorporated, a New York corporation ("Parent"), to purchase all
outstanding common shares, par value $1.00 per share (the "Shares"), of VWR
Scientific Products Corporation, a Pennsylvania corporation (the "Company"), at
a price of $37.00 per Share, net to the tendering shareholder in cash, upon the
terms and subject to the conditions set forth in Purchaser's Offer to Purchase
dated June 14, 1999 (the "Offer to Purchase") and in the related Letter of
Transmittal (which together constitute the "Offer").

Item 4.  The Solicitation or Recommendation

      (a) Item 4 is hereby amended by amending and restating in its entirety the
material under "The Solicitation or Recommendation - Recommendation of the Board
of Directors" as follows:

            "The Board, by unanimous vote of the Unaffiliated Directors acting
      as a quorum of the full Board, based upon, among other things, the
      unanimous recommendation and approval of the Special Committee (as that
      term is defined under " -- Background," below), has determined that the
      Merger Agreement and the transactions contemplated thereby, including each
      of the Offer and the Merger (collectively, the "Transactions"), are fair
      to, and in the best interests of, the Company and the shareholders of the
      Company not affiliated with the Parent (the "Public Shareholders"),
      approved the Merger Agreement, the Offer and the Merger, and resolved to
      recommend that shareholders accept the Offer and tender their Shares
      pursuant to the Offer and subsequently to approve the Merger Agreement, if
      such approval is required by law.

            In making the recommendation to the Company's Board and approving
      the Merger Agreement and the Transactions, the Unaffiliated Directors
      considered a number of factors, including, but not limited to, the
      following:

            (a) the financial and other terms and conditions of the Merger
      Agreement, including the proposed structure of the Offer and the Merger
      involving a cash tender offer of $37.00 per Share for all outstanding
      Shares, to be followed by a merger for the same consideration;

            (b) various risks and uncertainties associated with any expansion of
      the Company's distribution business to meet the needs of its global
      customers;

            (c) the historical market prices of the Shares, including the fact
      that the Offer price and the Merger price of $37.00 per Share represented
      premiums of approximately 29.0%, 32.1% and 32.7% over the closing prices
      per Share on the NASDAQ Stock Market June 3, 4, and 7, 1999, respectively,
      the last three full trading days prior to the June 8, 1999 announcement of
      the Transactions, and represented a premium of approximately 40% over
<PAGE>   3
      the closing price for the Shares on the NASDAQ Stock Market on the date 30
      days prior to the announcement of the Transactions;

            (d) according to Bloomberg LP, the $37.00 per Share to be paid to
      the Public Shareholders in the Offer and the Merger exceeded the highest
      price at which the Shares have closed on the NASDAQ Stock Market since the
      Company became a public company in 1986;

            (e) neither the Offer nor the Merger is subject to any financing
      condition, and that Parent has represented that it has available to it
      from or through Merck KGaA or its affiliates, sufficient funds to
      consummate the Offer, the Merger and the transactions contemplated
      thereby;

            (f) the separate opinions, each dated June 8, 1999, to the Company's
      Board and Special Committee, of BT Alex. Brown Incorporated ("BT Alex.
      Brown") (now merged with Deutsche Bank Securities Inc., and known as
      Deutsche Banc Alex. Brown) and Warburg Dillon Read LLC ("Warburg Dillon
      Read") to the effect that, as of the date of such opinions and based upon
      and subject to certain matters stated therein, the $37.00 per Share cash
      consideration to be received in the Offer and the Merger by the holders of
      Shares (other than Merck KGaA and its affiliates) was fair, from a
      financial point of view, to such holders. The full text of the written
      opinions of BT Alex. Brown and Warburg Dillon Read dated June 8, 1999, the
      analysis and conclusions of which were concurred with and adopted by the
      Company's Board and Special Committee and set forth the assumptions made,
      matters considered and limitations on the review undertaken, are attached
      as Annex A and Annex B, respectively, to this document and are
      incorporated herein by reference. The opinions of BT Alex. Brown and
      Warburg Dillon Read are directed to the Company's Board and Special
      Committee, address only the fairness of the $37.00 per Share cash
      consideration to be received in the Offer and the Merger by the holders of
      Shares (other than Merck KGaA and its affiliates) from a financial point
      of view, and do not constitute a recommendation to any shareholder as to
      whether or not such shareholder should tender Shares in the Offer or as to
      how such shareholder should vote with respect to the proposed Merger.
      Holders of Shares are urged to read such opinions carefully in their
      entirety;

            (g) the terms of the Merger Agreement were determined through
      arm's-length bargaining between the Special Committee and its legal and
      financial advisors, on one hand, and representatives of Parent, on the
      other, and provide for the Offer in order to allow Public Shareholders to
      receive payment for their Shares; and

            (h) Parent and its affiliates informed the Special Committee that it
      would not be interested in a third-party sale of the Company; the Special
      Committee and its financial advisors were not authorized to, and did not,
      solicit third-party indications of interest for the acquisition of the
      Company (which they deemed highly unlikely to receive in light to the
      aggregate ownership of the Company by the Parent and its affiliates and
      their affirmative disinterest in a third party sale of the Company), nor
      were any offers from third parties received; although the Unaffiliated
      Directors recognized that this factor did not necessarily support its
      determination regarding the fairness of the Transactions, the Unaffiliated


                                      -2-
<PAGE>   4
      Directors concluded that this factor was substantially outweighed by the
      totality of the other factors it considered in arriving at its
      determination.

            The Unaffiliated Directors recognized that the Merger had not been
      structured to require the approval of a majority of the Shares held by the
      Public Shareholders and that following successful completion of the Offer,
      the Parent and its affiliates would have sufficient voting power to
      approve the Merger Agreement without the affirmative vote of any other
      shareholder of the Company. However, the Unaffiliated Directors, including
      all of the members of the Special Committee, believed that the
      Transactions were procedurally fair because, among other things:

            (a) the Special Committee was appointed to represent the interests
      of the Public Shareholders;

            (b) by reason of the Standstill Agreement, completion of the Offer
      (and thus completion of the Merger) is conditioned upon its acceptance by
      the holders of a majority of the Shares not owned by the Parent and its
      affiliates; such condition may not be waived by the Purchaser without the
      consent of the Company and is designed to assure that the Public
      Shareholders holding a majority of the shares owned by all Public
      Shareholders have determined to accept the terms of the Offer prior to any
      vote on the Merger;

            (c) prior to consummation of the Offer, the Board of Directors may
      cause the Offer to be terminated if it receives an unsolicited proposal to
      be acquired by a third-party and, in the opinion of the Company's outside
      legal counsel, failure to consider such a proposal would result in a
      breach of the fiduciary duties of the Board of Directors under applicable
      law. Under such circumstances, the Company would be required to reimburse
      the Parent for its reasonable documented out-of-pocket expenses in an
      amount up to $8 million;

            (d) the Special Committee retained BT Alex. Brown and Warburg Dillon
      Read as its independent financial advisors to assist it in evaluating and
      negotiating a potential transaction with the Parent and its affiliates;

            (e) the Special Committee engaged in deliberations to evaluate the
      Transactions and alternatives thereto;

            (f) the $37.00 per Share price and the other terms and conditions of
      the Transaction resulted from active arm's-length bargaining between
      representatives of the Special Committee, on the one hand, and
      representatives of Parent and its affiliate, on the other; and

            (g) Public Shareholders may obtain "fair value" for their Shares if
      they exercise and perfect their appraisal rights under the PBCL.


                                      -3-
<PAGE>   5
      The Board of Directors' approval and recommendation was based on the
      totality of the information considered by it. The Board of Directors did
      not assign relative weights to the factors considered by it or determine
      that any one factor was of primary importance."

            After reasonable due inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.


July 6, 1999

                                    VWR SCIENTIFIC PRODUCTS CORPORATION



                                    By:  /s/David M. Bronson
                                         -------------------------------------
                                         Name:  David M. Bronson
                                         Title: Senior Vice President Finance


                                      -4-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission